Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

AGM Statement and Interim Management Statement

22 Jul 2014 07:00

RNS Number : 9489M
Renold PLC
22 July 2014
 



Renold plc

("Renold", "the Company" or "the Group")

 

AGM Statement and Interim Management Statement

 

Renold, a leading international supplier of industrial chains and related power transmission products, today issues its interim management statement covering the period from 1 April 2014 to the current date.

 

Strategic update

The final significant steps of the Bredbury closure project were completed during the first quarter as planned. The annualised savings arising from the project of £3.2m are in line with expectations and delivery has commenced slightly earlier than expected. Completion of the project will now allow more management time to be focussed on other continuous improvement initiatives to lower the Group's cost base further.

 

Financial update

Underlying (1) group revenue in the first quarter was 0.9% above the same period in the prior year. This reflects an improving trend relative to the 2.3% underlying revenue contraction in the first half of the prior year and the 0.8% contraction in the second half. The growth in the first quarter of the current year was driven by a combination of absolute growth in the Chain division and a further reduction in the rate of decline in Torque Transmission.

 

The combination of the early delivery of savings from the Bredbury factory closure, and other ongoing incremental actions to reduce the Group's breakeven point, have resulted in the Board's current expectations for the full year adjusted operating profit being above the current range of market forecasts, despite the adverse impact of foreign exchange movements.

 

There have been no other significant changes in the position of the Company over the period since the publication of the full year results for the year ended 31 March 2014.

 

Robert Purcell, Chief Executive of Renold, said:

"By completing the Bredbury closure project ahead of schedule we have accelerated the delivery of the resulting savings and also freed up management time to focus on new continuous improvement initiatives for the business. Self-help measures remain our priority and we are well placed to deliver further ongoing improvements in operational efficiencies and business processes which will generate additional reductions in our cost base."

 

22 July 2014

 

(1) The use of "underlying" excludes the impact of changes in foreign exchange rates.

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

Brian Tenner, Finance Director

Arden Partners

020 7614 5917

Chris Hardie

Instinctif Partners

020 7457 2020

Mark Garraway

Helen Tarbet

  

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGUGDRGXDBGSD
Date   Source Headline
12th Jul 20237:00 amRNSResults for the year ended 31 March 2023
10th Jul 20237:00 amRNSInvestor Presentation
19th Jun 20239:30 amRNSBlock Listing Six Monthly Return
18th May 20237:00 amRNSPreference Stock Dividend
9th May 20237:00 amRNSExtension of banking facilities
3rd May 202311:09 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update and Notice of Results
28th Mar 202312:53 pmRNSHolding(s) in Company
9th Mar 20237:00 amRNSNotice of Capital Markets Day
23rd Feb 202312:09 pmRNSHolding(s) in Company
10th Feb 20232:07 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSTrading Update
25th Jan 202310:00 amRNSHolding(s) in Company
24th Jan 20233:09 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSContract Win
19th Dec 20227:00 amRNSBlock Listing Six Monthly Return
8th Dec 20227:00 amRNSHolding(s) in Company
24th Nov 20225:18 pmRNSPreference Stock Dividend
16th Nov 20227:00 amRNSInterim Results
3rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
12th Oct 20229:12 amRNSHolding(s) in Company
5th Oct 20224:10 pmRNSHolding(s) in Company
20th Sep 202212:34 pmRNSGrant of Options
9th Sep 202211:37 amRNSDirector/PDMR Shareholding
6th Sep 202212:13 pmRNSResult of AGM
6th Sep 20227:00 amRNSAGM Trading Update
4th Aug 20227:30 amRNS2022 Annual Report & Notice of AGM
4th Aug 20227:00 amRNSAcquisition of Industrias YUK S.A.
13th Jul 20227:00 amRNSFinal results for the year ended 31 March 2022
8th Jul 20227:00 amRNSInvestor presentation
17th Jun 20227:00 amRNSBlock Listing Six Monthly Return
18th May 202212:18 pmRNSPreference Stock Dividend
4th May 20227:00 amRNSAppointment of Non-Executive Director
19th Apr 20223:53 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Update and Notice of Results
2nd Feb 20224:35 pmRNSPrice Monitoring Extension
25th Jan 20229:23 amRNSHolding(s) in Company
20th Jan 20224:42 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
20th Dec 202111:10 amRNSHolding(s) in Company
17th Dec 20218:43 amRNSBlock Listing Six Monthly Return
29th Nov 20213:15 pmRNSHolding(s) in Company
10th Nov 20217:00 amRNSInterim Results
8th Nov 20217:00 amRNSPreference Stock Dividend
5th Nov 20217:00 amRNSAppointment of Joint Broker
2nd Nov 202111:07 amRNSHolding(s) in Company
1st Nov 20211:04 pmRNSHolding(s) in Company
27th Oct 20217:00 amRNSNotice of Interim Results
20th Oct 20213:48 pmRNSHolding(s) in Company
31st Aug 202111:50 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.